Trial intelligence / Profile preview

Phase II study of TNF-Kinoid dosing schedules in adults with rheumatoid arthritis after relapse on prior anti-TNF therapy

2009-012041-35Phase 2Completed

Sponsor
Neovacs
Start
Sep 2009
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of tnf kinoid in rheumatoid arthritis (RA) (6 arms), sponsored by Neovacs. Started Sep 2009; status: completed.

02

Drugs

tnf kinoid
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2009-012041-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012041-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call